Jul 26, 2023 | Forensic AI Alerts
Wrapping Your Head Around Transcranial Magnetic Stimulation (TMS) Treatments and Utilization Patterns Mental illnesses represent a major public health issue because of their prevalence in the general population. Despite advances in psychopharmacology, it is...
Jun 27, 2023 | Forensic AI Alerts
Weight-loss Drug Shortages: Breeding Ground for Fraud and Future Health Issues Weight-loss drugs containing semaglutides, specifically Wegovy and Ozempic, have stolen headlines due to high demand and product shortages. Patients may seek alternative sources for...
May 30, 2023 | Forensic AI Alerts
Psychiatrists Performing Psychotherapy Evaluation & Management (E&M) Services Recently, several of our business partners expressed concerns with increased utilization by psychiatrists performing psychotherapy services and billing a high-level of...
Apr 25, 2023 | Forensic AI Alerts
Telephone E&M Services: When to “Make the Call” for Records Requests Telephone E&M services, specifically CPT (Current Procedural Terminology) 99441-99443, were infrequently utilized prior to the pandemic. After a thorough analysis, Codoxo...
Mar 28, 2023 | Forensic AI Alerts
Take a deep breath when reviewing asthma treatments When reviewing asthma treatments, Codoxo noted high utilization of chemotherapy injections by Allergy & Immunology specialists in association with medications to treat eosinophilic asthma and severe asthma. The...
Feb 27, 2023 | Forensic AI Alerts
Gains and Losses with Weight Loss Prescription Drugs Three weight-loss drugs are approved by the FDA (Food and Drug Administration) for persons with type 2 diabetes and obesity, and the names of the generic drug are tirzepatide, liraglutide, and semaglutide....
